Cardiogenic shock remains a challenging disease entity and is associated with significant
morbidity and mortality. Temporary mechanical circulatory support (MCS) can be …

Aims To compare the long-term outcomes of standard ablation of stable ventricular
tachycardia (VT) vs. substrate modification, and of complete vs. incomplete substrate …

Background—We report the experience in a cohort of consecutive patients receiving
extracorporeal membrane oxygenation during catheter ablation of unstable ventricular …

Background—Catheter ablation has become an established treatment modality for a broad
spectrum of ventricular tachycardias (VTs). We analyzed incidence and predictors of major …

The accepted use of left ventricular assist device (LVAD) technology as a good alternative
for the treatment of patients with advanced heart failure together with the improved survival …

Background—Data on relative safety, efficacy, and role of different percutaneous left
ventricular assist devices for hemodynamic support during the ventricular tachycardia (VT) …

Background—Percutaneous left ventricular assist devices (pLVADs) are increasingly being
used to facilitate ablation of unstable ventricular tachycardia (VT), but the safety profile and …

Purpose Patient selection and timing of percutaneous left ventricular assist device (pLVAD)
insertion for maximal benefit during ventricular tachycardia (VT) ablation is not well defined …

Substrate vs. Activation/Entrainment Guided VT Ablation Introduction Substrate‐based
ablation for scar‐related ventricular tachycardia (VT) has gained prominence: however …

Objectives: This study sought to evaluate the clinical outcomes of patients receiving
hemodynamic support (HS) during ventricular tacchycardia (VT) ablation. Background …